Rowshan Reordan

From WikiMD's Food, Medicine & Wellness Encyclopedia

Rowshan Reordan[edit | edit source]

Rowshan Reordan is a prominent figure in the field of pharmacology and biotechnology. She is the founder and CEO of Green Leaf Lab, a leading cannabis and hemp testing laboratory in the United States.

Early Life and Education[edit | edit source]

Rowshan Reordan was born and raised in California. She pursued her undergraduate studies in Biology at the University of California, and later obtained her Master's degree in Pharmacology from the same institution.

Career[edit | edit source]

After completing her education, Reordan worked in various roles in the pharmaceutical industry, gaining experience in drug development and regulatory affairs. In 2011, she founded Green Leaf Lab, a cannabis and hemp testing laboratory. Under her leadership, the lab has become one of the leading testing facilities in the United States, known for its rigorous testing standards and commitment to consumer safety.

Contributions to Pharmacology[edit | edit source]

Reordan's work in the field of cannabis testing has significantly contributed to the advancement of pharmacology. Her lab's rigorous testing methods have helped to ensure the safety and efficacy of cannabis products, and her advocacy for stringent testing standards has influenced regulatory policies in the cannabis industry.

Recognition[edit | edit source]

Reordan's contributions to the field of pharmacology and the cannabis industry have been recognized by several organizations. She has received numerous awards for her leadership and innovation, and is frequently invited to speak at industry conferences and events.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

  • [Official Website of Green Leaf Lab]
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD